| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.021 | 0.9 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.02 | 0.9 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |